NGEN
NervGen Pharma Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.60
-0.27 ▼ -6.98%
🌙 3월 13일 5:04 PM ET (한국 3/14 06:04)
$3.66
+0.06 ▲ +1.67%
| Index | - | P/E | - | EPS (ttm) | -0.26 | Insider Own | 21.5% | Shs Outstand | 0.07B | Perf Week | -10.45% |
| Market Cap | 0.29B | Forward P/E | - | EPS next Y | -30.18% | Insider Trans | - | Shs Float | 0.06B | Perf Month | -12.2% |
| Enterprise Value | 0.28B | PEG | - | EPS next Q | -0.06 | Inst Own | 0.06% | Short Float | 2.1% | Perf Quarter | -15.62% |
| Income | -0.02B | P/S | - | EPS this Y | 15.43% | Inst Trans | -2.88% | Short Ratio | 9.45 | Perf Half Y | 35.85% |
| Sales | 0.00B | P/B | - | EPS next 5Y | -6.55% | ROA | -142.21% | Short Interest | 1.31M | Perf YTD | -35.71% |
| Book/sh | -0.03 | P/C | 34.98 | EPS past 3/5Y | -0.24% 1.73% | ROE | -790.82% | 52W High | -42.86% ($6.30) | Perf Year | 89.17% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 140% ($1.50) | Perf 3Y | 182.35% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 4.53% | Gross Margin | - | Volatility(W/M) | 6.69% 6.75% | Perf 5Y | 132.33% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.79 | EPS Q/Q | 24.68% | Profit Margin | - | RSI (14) | 35.73 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.79 | Sales Q/Q | - | SMA20 | -12.1% ($4.1) | Beta | 0.98 | Target Price | $5.97 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -21.48% ($4.58) | Rel Volume | 1.26 | Prev Close | $3.87 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | 30.1% - | SMA200 | 7.69% ($3.34) | Avg Volume(3M) | 0.14M | Price | $3.6 |
| IPO | 2019/4/3 | Option/Short | Yes/Yes | Trades | 682 | Volume | 175,057 | Change | -6.98% |
뉴스 로딩 중...